{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:10:21Z","timestamp":1763017821936,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005348","name":"Ministry of Health and Social Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201507930005"],"award-info":[{"award-number":["201507930005"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Swedish Research Council for Health, Working Life and Welfare","doi-asserted-by":"publisher","award":["2014-01382"],"award-info":[{"award-number":["2014-01382"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2015-02531"],"award-info":[{"award-number":["2015-02531"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ijcard.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T09:46:06Z","timestamp":1509875166000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Atrial fibrillation and use of antithrombotic medications in older people: A population-based study"],"prefix":"10.1016","volume":"249","author":[{"given":"Mozhu","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Fratiglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Johnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Fastbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ljungdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.07.012_bb0005","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham heart study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0015","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","article-title":"Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study","volume":"44","author":"Bj\u00f6rck","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0020","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","article-title":"Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0030","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0035","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0045","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0050","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/europace\/euw073","article-title":"Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation (GLORIA-AF) phase I cohort","volume":"18","author":"Huisman","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0055","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijcard.2014.09.201","article-title":"Patterns of cardiovascular drugs prescribed for an elderly Swedish population","volume":"177","author":"Ding","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1253\/circj.CJ-15-1237","article-title":"Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation. Shinken database analysis","volume":"80","author":"Suzuki","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamainternmed.2013.1579","article-title":"Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992\u20132007)","volume":"173","author":"Shroff","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0075","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/ageing\/afw076","article-title":"Association of mobility limitations with incident disability among older adults: a population-based study","volume":"45","author":"Heiland","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glw233","article-title":"Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization","author":"Calder\u00f3n-Larra\u00f1aga","year":"2016","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.recesp.2013.07.015","article-title":"Prevalence of atrial fibrillation in Spain. OFRECE study results","volume":"67","author":"G\u00f3mez-Doblas","year":"2014","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0105","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994\u20131998","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2796.2012.02519.x","article-title":"The prevalence of atrial fibrillation in a geographically well-defined population in Northern Sweden: implications for anticoagulation prophylaxis","volume":"272","author":"Andersson","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0120","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/CIRCULATIONAHA.115.016715","article-title":"Should patients with atrial fibrillation and 1 stroke risk factor (CHA2DS2-VASc score 1 in men, 2 in women) be anticoagulated? The CHA2DS2-VASc 1 conundrum: decision making at the lower end of the risk spectrum","volume":"133","author":"Savino","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0130","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0135","article-title":"Atrial Fibrillation: The Mmanagement of Aatrial Ffibrillation","volume":"180","author":"National Institute for Health and Care Excelence","year":"2014"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2016.02.023","article-title":"Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: a population-based cohort study","volume":"140","author":"Mochalina","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2013.10.063","article-title":"Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system","volume":"170","author":"Forslund","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2013European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE registry","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12872-016-0235-1","article-title":"Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study","volume":"16","author":"Vanbeselaere","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.amjmed.2016.11.001","article-title":"Absence of oral anticoagulation and subsequent outcomes among outpatients with atrial fibrillation","volume":"130","author":"Hess","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.14503\/THIJ-16-5785","article-title":"Underuse of oral anticoagulants for nonvalvular atrial fibrillation: past, present, and future","volume":"43","author":"Wehbe","year":"2016","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2296-13-5","article-title":"Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis","volume":"13","author":"Baczek","year":"2012","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STROKEAHA.107.495036","article-title":"Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians","volume":"39","author":"Gattellari","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0190","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation: a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0200","doi-asserted-by":"crossref","first-page":"e004301","DOI":"10.1136\/bmjopen-2013-004301","article-title":"Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation","volume":"4","author":"Cameron","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2017.07.012_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/joim.12001","article-title":"Managing anticoagulation for atrial fibrillation: current issues and future strategies","volume":"273","author":"John","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","article-title":"\u201cReal-world\u201d antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey","volume":"127","author":"Lip","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2017.07.012_bb0215","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehr134","article-title":"Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA","volume":"32","author":"Wieloch","year":"2011","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317327845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317327845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T08:25:17Z","timestamp":1535271917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317327845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":43,"alternative-id":["S0167527317327845"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.07.012","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation and use of antithrombotic medications in older people: A population-based study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}